Kumar Neil 的 Form 4 申報
BridgeBio Pharma, Inc.（BBIO），2025/11/10 申報
- 申報編號
- 0001470831-25-000302
- 申報時間
- 2025/11/10
- 交易日
- 2025/11/6-11/7
- 申報延遲
- 4 天
- 10b5-1 計畫
- 有勾選
這份申報列了 12 筆非衍生性交易。公開市場賣出合計 $498.3 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Kumar NeilCIK 0001742485 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/11/6 | Common Stock | S賣出處分 | −12,576 | $62.91F2 | −$791,156.16 | 4,625,871 | 間接 | |
| 2025/11/6 | Common Stock | S賣出處分 | −7,324 | $63.55F4 | −$465,440.2 | 4,618,547 | 間接 | |
| 2025/11/6 | Common Stock | S賣出處分 | −100 | $64.39 | −$6,439 | 4,618,447 | 間接 | |
| 2025/11/7 | Common Stock | S賣出處分 | −12,492 | $61.14F5 | −$763,760.88 | 4,605,955 | 間接 | |
| 2025/11/7 | Common Stock | S賣出處分 | −7,308 | $61.87F6 | −$452,145.96 | 4,598,647 | 間接 | |
| 2025/11/7 | Common Stock | S賣出處分 | −200 | $62.81F7 | −$12,562 | 4,598,447 | 間接 | |
| 2025/11/6 | Common Stock | S賣出處分 | −12,529 | $62.91F2 | −$788,199.39 | 823,157 | 間接 | |
| 2025/11/6 | Common Stock | S賣出處分 | −7,371 | $63.56F4 | −$468,500.76 | 815,786 | 間接 | |
| 2025/11/6 | Common Stock | S賣出處分 | −100 | $64.39 | −$6,439 | 815,686 | 間接 | |
| 2025/11/7 | Common Stock | S賣出處分 | −12,234 | $61.13F8 | −$747,864.42 | 803,452 | 間接 | |
| 2025/11/7 | Common Stock | S賣出處分 | −7,546 | $61.87F9 | −$466,871.02 | 795,906 | 間接 | |
| 2025/11/7 | Common Stock | S賣出處分 | −220 | $62.79F10 | −$13,813.8 | 795,686 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents the weighted average sale price of the shares sold from $62.245 to $63.24 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 2 筆交易的價格引用這則附註。
- F4
Represents the weighted average sale price of the shares sold from $63.25 to $64.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 2 筆交易的價格引用這則附註。
- F5
Represents the weighted average sale price of the shares sold from $60.59 to $61.58 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents the weighted average sale price of the shares sold from $61.59 to $62.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents the weighted average sale price of the shares sold from $62.78 to $62.83 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents the weighted average sale price of the shares sold from $60.57 to $61.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F9
Represents the weighted average sale price of the shares sold from $61.58 to $62.37 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F10
Represents the weighted average sale price of the shares sold from $62.68 to $62.83 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。